We are live on
!
Find out more
IPC
Independent Portfolio Consultants Portfolio holdings
AUM
$241M
1-Year Est. Return
21.8%
This Fund
S&P 500
This Quarter
Est. Return
+2.38%
1 Year Est. Return
+21.8%
3 Year Est. Return
+32.36%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$223M
AUM Growth
–
Cap. Flow
+$225M
Cap. Flow
% of AUM
100.72%
Top 10 Holdings %
Top 10 Hldgs %
7.34%
Holding
425
New
425
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$1.96M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$1.79M |
| 3 |
Sanofi
SNY
|
+$1.78M |
| 4 |
GSK
GSK
|
+$1.74M |
| 5 |
Affiliated Managers Group
AMG
|
+$1.65M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 13.37% |
| 2 | Technology | 12.8% |
| 3 | Financials | 11.97% |
| 4 | Healthcare | 11.66% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Morgan Stanley
MS
$337B
| $286K | 0.13% |
+11,710
| New | +$278K |
|
327
CSX Corp
CSX
$95B
| $285K | 0.13% |
+36,909
| New | +$303K |
|
|
POLY
328
DELISTED
Plantronics, Inc.
POLY
| $283K | 0.13% |
+6,445
| New | +$289K |
|
329
A.O. Smith
AOS
$8.21B
| $282K | 0.13% |
+15,560
| New | +$291K |
|
330
Evercore
EVR
$11.2B
| $282K | 0.13% |
+7,180
| New | +$278K |
|
331
Enerpac Tool Group
EPAC
$1.92B
| $280K | 0.13% |
+8,500
| New | +$272K |
|
332
H.B. Fuller
FUL
$3.03B
| $280K | 0.13% |
+7,400
| New | +$292K |
|
|
SPLS
333
DELISTED
Staples Inc
SPLS
| $280K | 0.13% |
+17,640
| New | +$253K |
|
|
FITB
334
Fifth Third Bancorp
FITB
$49.5B
| $279K | 0.13% |
+15,452
| New | +$269K |
|
|
MRH
335
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
| $278K | 0.12% |
+11,130
| New | +$284K |
|
|
CFN
336
DELISTED
CAREFUSION CORPORATION
CFN
| $278K | 0.12% |
+7,555
| New | +$267K |
|
|
AKZOY
337
DELISTED
Akzo Nobel NV
AKZOY
| $278K | 0.12% |
+14,820
| New | +$278K |
|
338
American International
AIG
$40.2B
| $277K | 0.12% |
+6,200
| New | +$266K |
|
339
Procter & Gamble
PG
$334B
| $274K | 0.12% |
+3,555
| New | +$279K |
|
340
ICU Medical
ICUI
$4.38B
| $272K | 0.12% |
+3,775
| New | +$250K |
|
|
TIF
341
DELISTED
Tiffany & Co.
TIF
| $272K | 0.12% |
+3,730
| New | +$278K |
|
342
Saia
SAIA
$9.37B
| $271K | 0.12% |
+9,059
| New | +$258K |
|
|
MSCC
343
DELISTED
Microsemi Corp
MSCC
| $271K | 0.12% |
+11,925
| New | +$255K |
|
|
BRLI
344
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $269K | 0.12% |
+9,345
| New | +$258K |
|
345
Dine Brands
DIN
$425M
| $267K | 0.12% |
+3,870
| New | +$274K |
|
346
Perrigo
PRGO
$2.01B
| $267K | 0.12% |
+2,210
| New | +$262K |
|
347
Cheesecake Factory
CAKE
$5.58B
| $264K | 0.12% |
+6,295
| New | +$251K |
|
348
Selective Insurance
SIGI
$5.51B
| $264K | 0.12% |
+11,478
| New | +$270K |
|
|
MBFI
349
DELISTED
MB Financial Corp
MBFI
| $264K | 0.12% |
+9,865
| New | +$247K |
|
350
Sensient Technologies
SXT
$5.75B
| $261K | 0.12% |
+6,450
| New | +$256K |
|
Similar funds
KC
TC
FRM
WFG
IFB
KL
RP
BJCM
Independent Portfolio Consultants's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Independent Portfolio Consultants, which disclosed 425 positions worth $223M. Its ten largest holdings account for 7.3% of the portfolio.
Its largest position is Novartis: 30,184 shares worth $1.91M.
By sector, the portfolio is most concentrated in Industrials at 13% of assets, followed by Technology and Financials.
- Independent Portfolio Consultants's largest Q2 2013 buy was Novartis: 30,184 shares worth $1.91M.
- Independent Portfolio Consultants's ten largest holdings make up 7.3% of its $223M portfolio in Q2 2013.
- Independent Portfolio Consultants disclosed 425 positions in Q2 2013, its first 13F filing on record.
Based on Independent Portfolio Consultants's 13F filing for Q2 2013, filed 12 Jul 2013.